ZOLGENSMA 2 x 10 000 000 000 000 du vecteur/ml, solution for infusion bottle, 5.5 ml, CIP 3400955075110
Active ingredients: ONASEMNOGÈNE ABÉPARVOVEC
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for infusionbottle, 5.5 ml, CIP 3400955075110intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ZOLGENSMA 2 x 10 000 000 000 000 du vecteur/mL, solution pour perfusion
- Pharmaceutical form
- solution pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 5,5 ml - 3 flacon(s) de 8,3 ml
- Marketing authorisation holder
- NOVARTIS EUROPHARM (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 19 May 2021
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
69200149CIP75507511CIP133400955075110Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ONASEMNOGÈNE ABÉPARVOVECsolution | 2 x 10 000 000 000 000 génomes du vecteur · 1 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
- 2 bottles of 8.3 mlCommercialized according to BDPM
- 2 bottles of 5.5 ml, CIP 3400955075073Commercialized according to BDPM
- bottle, 5.5 ml, CIP 3400955075080Commercialized according to BDPM
- 3 bottles of 8.3 mlCommercialized according to BDPM
- 2 bottles of 5.5 ml, CIP 3400955075103Commercialized according to BDPM
- 4 bottles of 8.3 mlCommercialized according to BDPM
- 2 bottles of 5.5 ml, CIP 3400955075134Commercialized according to BDPM
- bottle, 5.5 ml, CIP 3400955075141Commercialized according to BDPM
- 5 bottles of 8.3 mlCommercialized according to BDPM
- 2 bottles of 5.5 ml, CIP 3400955075165Commercialized according to BDPM
- bottle, 5.5 ml, CIP 3400955075172Commercialized according to BDPM
- 6 bottles of 8.3 mlCommercialized according to BDPM
- 2 bottles of 5.5 ml, CIP 3400955075202Commercialized according to BDPM
- bottle, 5.5 ml, CIP 3400955075219Commercialized according to BDPM
- 7 bottles of 8.3 mlCommercialized according to BDPM
- 2 bottles of 5.5 ml, CIP 3400955075233Commercialized according to BDPM
- bottle, 5.5 ml, CIP 3400955075240Commercialized according to BDPM
- 8 bottles of 8.3 mlCommercialized according to BDPM
- 2 bottles of 5.5 ml, CIP 3400955075271Commercialized according to BDPM
- bottle, 5.5 ml, CIP 3400955075288Commercialized according to BDPM
- 9 bottles of 8.3 mlCommercialized according to BDPM
- 2 bottles of 5.5 ml, CIP 3400955075301Commercialized according to BDPM
- bottle, 5.5 ml, CIP 3400955075325Commercialized according to BDPM
- 10 bottles of 8.3 mlCommercialized according to BDPM
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.